Literature DB >> 7899153

Bipolar hemiarthroplasty for primary osteoarthritis of the hip.

D Prieskorn1, P Burton, B J Page, J Swienckowski.   

Abstract

One hundred twenty-five bipolar hemiarthroplasties of the hip were performed at the authors' hospital. Although the procedure was performed for acute femoral neck fractures, rheumatoid arthritis, revision hemiarthroplasty, and primary osteoarthritis, only the latter is the subject of this review. A modified Harris hip score (HHS) was used to evaluate the patients both preoperatively and postoperatively. Radiographs were taken preoperatively as well as postoperatively at 2-, 4-, 6-, and 24-month intervals. A total of 68 patients underwent bipolar hemiarthroplasty for primary hip osteoarthritis. The mean preoperative HHS was 35.5 (SEM = 1.86); the mean postoperative score was 81.2 (SEM = 1.64) with an average improvement of 45.7 (SEM = 2.03). The results of this review were compared to a control group of conventional total hip arthroplasties performed at the same institution. The mean postoperative HHS for the group of conventional arthroplasties was 87.2 (SEM = 1.07). The results of this review indicate a good clinical result from bipolar hemiarthroplasty, but significantly less postoperative function when compared to conventional total hip arthroplasty.

Entities:  

Mesh:

Year:  1994        PMID: 7899153     DOI: 10.3928/0147-7447-19941201-04

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  2 in total

1.  Long-term clinical results of bipolar hemiarthroplasty for osteoarthritis and rheumatoid arthritis of the hip: A retrospective study.

Authors:  Tetsutaro Abe; Nobuhiro Kaku; Tomonori Tabata; Hiroaki Tagomori; Hiroshi Tsumura
Journal:  J Orthop       Date:  2019-08-12

2.  Reasons for revision of failed hemiarthroplasty: Are there any differences between unipolar and bipolar?

Authors:  Khanin Iamthanaporn; Keerati Chareancholvanich; Chaturong Pornrattanamaneewong
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.